Evaluation of antibiotic susceptibilities of Ehrlichia canis, Ehrlichia chaffeensis, and Anaplasma phagocytophilum by real-time PCR

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 12, 2004, Pages 4822-4828

  Branger, S ^a   Rolain, J M ^a   Raoult, D ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; MACROLIDE; OFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULFAMETHOXAZOLE; TELITHROMYCIN; THIAMPHENICOL; TRIMETHOPRIM; VIRUS RNA;

ANAPLASMA PHAGOCYTOPHILUM; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SCREENING; DRUG SENSITIVITY; DRUG SPECIFICITY; EHRLICHIA CANIS; EHRLICHIA CHAFFEENSIS; ESCHERICHIA COLI; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; STAINING;

ANAPLASMA PHAGOCYTOPHILUM; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; COLORING AGENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; EHRLICHIA CANIS; EHRLICHIA CHAFFEENSIS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 23S;

EID: 9744261697     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.12.4822-4828.2004     Document Type: Article

References (48)

1. Barton, L. L., and T. M. Foy. 1989. Ehrlichia canis infection in a child. Pediatrics 84:580-582.
2. Blanco, J. R., and J. A. Oteo. 2002, Human granulocytic ehrlichiosis in Europe. Clin. Microbiol. Infect. 8:763-772.
3. Boulos, A., J. M. Rolain, M. Maurin, and D. Raoult. 2004. Evaluation of antibiotic susceptibilities against Coxiella burnetii by real time PCR. Int. J. Antimicrob. Agents 23:169-174.
4. Boulos, A., J. M. Rolain, and D. Raoult. 2004. Antibiotic susceptibility of Tropheryma whipplei in MRC5 cells. Antimicrob. Agents Chemother. 48:747-752.
5. Brennan, R. E., and J. E. Samuel. 2003. Evaluation of Coxiella burnetii antibiotic susceptibilities by real-time PCR assay. J. Clin. Microbiol. 41:1869-1874.
6. Brouqui, P., and D. Raoult. 1990. In vitro susceptibility of Ehrlichia sennetsu to antibiotics. Antimicrob. Agents Chemother. 34:1593-1596.
7. Brouqui, P., and D. Raoult. 1992. In vitro antibiotic susceptibility of the newly recognized agent of ehrlichiosis in humans, Ehrlichia chaffeensis. Antimicrob. Agents Chemother. 36:2799-2803.
8. Brouqui, P., and D. Raoult. 1993. Susceptibilities of Ehrlichiae to antibiotics, p. 179-199. In D. Raoult (ed.), Antimicrobial agents and intracellular pathogens. CRC Press, Boca Raton, Fla.
9. Buitrago, M. I., J. W. Ijdo, P. Rinaudo, H. Simon, J. Copel, J. Gadbaw, R. Heimer, E. Fikrig, and F. J. Bia. 1998. Human granulocytic ehrlichiosis during pregnancy treated successfully with rifampin. Clin. Infect. Dis. 27:213-215.
10. Cannon, M., S. Harford, and J. Davies. 1990. A comparative study on the inhibitory actions of chloramphenicol, thiamphenicol and some fluorinated derivatives. J. Antimicrob. Chemother. 26:307-317.
11. Doran, T. I., R. T. Parmley, P. C. Logas, and S. Chamblin. 1989. Infection with Ehrlichia canis in a child. J. Pediatr. 114:809-812.
12. Dumler, J. S. 1997. Is human granulocytic ehrlichiosis a new Lyme disease? Review and comparison of clinical, laboratory, epidemiological, and some biological features. Clin. Infect. Dis. 25:S43-S47.
13. Dumler, J. S., and J. S. Bakken. 1995. Ehrlichial diseases of humans: emerging tick-borne infections. Clin. Infect. Dis. 20:1102-1110.
14. Dumler, J. S., and J. S. Bakken. 1998. Human ehrlichioses: newly recognized infections transmitted by ticks. Annu. Rev. Med. 49:201-213.
15. Dumler, J. S., A. F. Barbet, C. P. Bekker, G. A. Dasch, G. H. Palmer, S. C. Ray, Y. Rikihisa, and F. R. Rurangirwa. 2001. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and 'HGE agent' as subjective synonyms of Ehrlichia phagocytophila. Int. J. Syst. Evol. Microbiol. 51:2145-2165.
16. Dumler, J. S., P. Brouqui, J. Aronson, J. P. Taylor, and D. H. Walker. 1991. Identification of Ehrlichia in human tissue. N. Engl. J. Med. 325:1109-1110.
17. Eng, T. R., D. B. Fishbein, J. E. Dawson, C. R. Greene, and M. Redus. 1990. Surveillance of human ehrlichiosis in the United States: 1988. Ann. N. Y. Acad. Sci. 590:306-307.
18. Fenollar, F., M. Maurin, and D. Raoult. 2003. Wolbachia pipientis growth kinetics and susceptibilities to 13 antibiotics determined by immunofluorescence staining and real-time PCR. Antimicrob. Agents Chemother. 47:1665-1671.
19. Fishbein, D. B., J. E. Dawson, and L. E. Robinson. 1994. Human ehrlichiosis in the United States, 1985 to 1990. Ann. Intern. Med. 120:736-743.
20. Goodman, J. L., C. Nelson, B. Vitale, J. E. Madigan, J. S. Dumler, T. J. Kurtti, and U. G. Munderloh. 1996. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N. Engl. J. Med. 334:209-215.
21. Harkess, J. R., S. A. Ewing, T. Brumit, and C. R. Mettry. 1991. Ehrlichiosis in children. Pediatrics 87:199-203.
22. Harrus, S., T. Waner, I. Aizenberg, and H. Bark. 1998. Therapeutic effect of doxycycline in experimental subclinical canine monocytic ehrlichiosis: evaluation of a 6-week course. J. Clin. Microbiol. 36:2140-2142.
23. Horowitz, H. W., T.-C. Hsieh, M. E. Aguero-Rosenfeld, F. Kalantarpour, I. Chowdhury, G. P. Wormser, and J. M. Wu. 2001. Antimicrobial susceptibility of Ehrlichia phagocytophila. Antimicrob. Agents Chemother. 45:786-788.
24. Horowitz, H. W., E. Kilchevsky, S. Haber, M. Aguero-Rosenfeld, R. KranWinkel, E. K. James, S. J. Wong, F. Chu, D. Liveris, and I. Schwartz. 1998. Perinatal transmission of the agent of human granulocytic ehrlichiosis. N. Engl. J. Med. 339:375-378.
25. Hulinska, D., J. Votypka, J. Plch, E. Vlcek, M. Valesova, M. Bojar, V. Hulinsky, and K. Smetana. 2002. Molecular and microscopical evidence of Ehrlichia spp. and Borrelia burgdorferi sensu lato in patients, animals and ticks in the Czech Republic. New Microbiol. 25:437-448.
26. Iqbal, Z., and Y. Rikihisa. 1994. Reisolation of Ehrlichia canis from blood and tissues of dogs after doxycycline treatment. J. Clin. Microbiol. 32:1644-1649.
27. Karlsson, U., A. Bjoersdorff, R. F. Massung, and B. Christensson. 2001. Human granulocytic ehrlichiosis - a clinical case in Scandinavia. Scand. J. Infect. Dis. 33:73-74.
28. Klein, M. B., C. M. Nelson, and J. L. Goodman. 1997. Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins. Antimicrob. Agents Chemother. 41:76-79.
29. Krause, P. J., C. L. Corrow, and J. S. Bakken. 2003. Successful treatment of human granulocytic ehrlichiosis in children using rifampin. Pediatrics 112:e252-e253.
30. Lin, M., and Y. Rikihisa. 2003. Ehrlichia chaffeensis and Anaplasma phagocytophilum lack genes for lipid A biosynthesis and incorporate cholesterol for their survival. Infect. Immun. 71:5324-5331.
31. Masselot, F., A. Boulos, M. Maurin, J. M. Rolain, and D. Raoult. 2003. Molecular evaluation of antibiotic susceptibility: the Tropheryma whipplei paradigm. Antimicrob. Agents Chemother. 47:1658-1664.
32. Maurin, M., C. Abergel, and D. Raoult. 2001. DNA gyrase-mediated natural resistance to fluoroquinolones in Ehrlichia spp. Antimicrob. Agents Chemother. 45:2098-2105.
33. Maurin, M., J. S. Bakken, and J. S. Dumler. 2003. Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States. Antimicrob. Agents Chemother. 47:413-415.
34. McCormack, W. M. 1993. Susceptibility of mycoplasmas to antimicrobial agents: clinical implications. Clin. Infect. Dis. 17(Suppl. 1):S200-S201.
35. Parola, P., V. Roux, J. L. Camicas, I. Baradji, P. Brouqui, and D. Raoult. 2000. Detection of ehrlichiae in African ticks by polymerase chain reaction. Trans. R. Soc. Trop. Med. Hyg. 94:707-708.
36. Pereyre, S., P. Gonzalez, B. de Barbeyrac, A. Darnige, H. Renaudin, A. Charron, S. Raherison, C. Bebear, and C. M. Bebear. 2002. Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis. Antimicrob. Agents Chemother. 46:3142-3150.
37. Remy, V., Y. Hansmann, S. De Martino, D. Christmann, and P. Brouqui. 2003. Human anaplasmosis presenting as atypical pneumonitis in France. Clin. Infect. Dis. 37:846-848.
38. Rikihisa, Y., N. Zhi, G. P. Wormser, B. H. Wen, H. W. Horowitz, and K. E. Hechemy. 1997. Ultrastructural and antigenic characterization of a granulocytic ehrlichiosis agent directly isolated and stably cultivated from a patient in New York State. J. Infect. Dis. 175:210-213.
39. Rolain, J. M., M. N. Mallet, P. E. Fournier, and D. Raoult. 2004. Real-time PCR for universal antibiotic susceptibility testing. J. Antimicrob. Chemother. 54:538-541.
40. Rolain, J. M., M. Maurin, A. Bryskier, and D. Raoult. 2000. In vitro activities of telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowasekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella baciltiformis, and Ehrlichia chaffeensis. Antimicrob. Agents Chemother. 44:1391-1393.
41. Rolain, J. M., L. Stuhl, M. Maurin, and D. Raoult. 2002. Evaluation of antibiotic susceptibilities of three rickettsial species including Rickettsia felis by a quantitative PCR DNA assay. Antimicrob. Agents Chemother. 46:2747-2751.
42. Ross, J. I., E. A. Eady, J. H. Cove, C. E. Jones, A. H. Ratyal, Y. W. Miller, S. Vyakrnam, and W. J. Cunliffe. 1997. Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA. Antimicrob. Agents Chemother. 41:1162-1165.
43. Skolimowski, I. M., R. C. Knight, and D. I. Edwards. 1983. Molecular basis of chloramphenicol and thiamphenicol toxicity to DNA in vitro. J. Antimicrob. Chemother. 12:535-542.
44. Vester, B., and S. Douthwaite. 2001. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob. Agents Chemother. 45:1-12.
45. Walker, D. H., and J. S. Dumler. 1996. Emergence of the ehrlichioses as human health problems. Emerg. Infect. Dis. 2:1-15.
46. Webster, P., J. W. Ijdo, L. M. Chicoine, and E. Fikrig. 1998. The agent of human granulocytic ehrlichiosis resides in an endosomal compartment. J. Clin. Investig. 101:1932-1941.
47. Wellman, M. L., S. Krakowka, R. M. Jacobs, and G. J. Kociba. 1988. A macrophage-monocyte cell line from a dog with malignant histiocytosis. In Vitro Cell. Dev. Biol. 24:223-229.
48. Xiong, L., S. Shah, P. Mauvais, and A. S. Mankin. 1999. A ketolide resistance mutation in domain II of 23S rRNA reveals the proximity of hairpin 35 to the peptidyl transferase centre. Mol. Microbiol. 31:633-639.